SMTL ID : 7nxk.2 (1 other biounit)

Crystal structure of human Cdk12/Cyclin K in complex with the inhibitor BSJ-01-175

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

hetero-1-1-mer

Ligands

1 x UUB: (E)-N-[4-[(1R,3R)-3-[[5-chloranyl-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]cyclohexyl]oxyphenyl]-4-(dimethylamino)but-2-enamide(Covalent)

UUB.1: 13 residues within 4Å: Chain A: I.20, I.21, G.22, E.23, V.29, F.101, Y.103, M.104, D.105, L.154, D.165, D.326, C.327 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:I.21, A:I.21, A:V.29, A:D.326 Hydrogen bonds: A:M.104, A:M.104 Water bridges: A:D.165, A:D.165

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jiang, B. et al., Structure-activity relationship study of THZ531 derivatives enables the discovery of BSJ-01-175 as a dual CDK12/13 covalent inhibitor with efficacy in Ewing sarcoma. Eur.J.Med.Chem. (2021)

Release Date

2021-05-12

Peptides

Cyclin-dependent kinase 12: A
Cyclin-K: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Cyclin-dependent kinase 12

Cyclin-K

Related Entries With Identical Sequence